Hemagglutination Assay- Principle, Types, Method, Uses

Hemagglutination assay is a laboratory technique that can detect the presence of antibodies or antigens in a biological sample by observing the agglutination (clumping) of red blood cells (RBCs). Hemagglutination assay is based on the principle that when RBCs are coated with antigens or antibodies, they can bind to their complementary counterparts in the sample and form visible clumps. The absence of clumps indicates a negative result, meaning that the sample does not contain the target antibodies or antigens.

Hemagglutination assay can be used for various purposes, such as:

• Determining blood types or groups

• Detecting viral or bacterial infections

• Measuring the humoral immune response to pathogens or vaccines

• Diagnosing certain diseases or conditions

Hemagglutination assay is a simple, inexpensive, and fast technique that can be performed in a laboratory or in the field using rapid diagnostic test (RDT) kits. However, hemagglutination assay also has some limitations, such as:

• The need for specific and standardized reagents and conditions

• The possibility of false positive or negative results due to non-specific agglutination or interference factors

• The requirement of trained personnel and manual interpretation of results

• The lack of digital data and quantitative values

There are two main types of hemagglutination assay: rapid hemagglutination assay and micro-hemagglutination assay. Rapid hemagglutination assay can be performed on a glass slide or a tile using drops of RBC suspension and sample. Micro-hemagglutination assay can be performed on a microplate using microliters of RBC suspension and sample. Both types of hemagglutination assay have their own advantages and disadvantages, which will be discussed in detail in the following sections.

The hemagglutination assay is a simple and inexpensive method to detect the presence of antibodies or antigens in a serum or blood sample. The basic principle of the assay is that when red blood cells (RBCs) are coated with antigens or antibodies that are complementary to those in the sample, they will clump together (agglutinate) and form visible clumps. The absence of clumps indicates a negative result.

To perform the hemagglutination assay, the following requirements are needed:

• RBC suspension: This is the carrier particle that is coated with antigens or antibodies that are specific to the ones to be detected in the sample. The RBCs can be obtained from humans, sheep, chicks, or other animals, depending on the type of assay. The RBC suspension should be prepared at a suitable concentration (usually 0.5% to 10%) and stored at 4°C until use.

• Serum or blood sample: This is the test sample that contains the antibodies or antigens of interest. The sample should be collected and stored according to standard procedures and diluted appropriately before use. The sample volume should be sufficient to perform the assay and repeat it if necessary.

• Microtitre plates: These are plastic plates that have multiple wells (usually 96) where the RBC suspension and the sample are mixed and incubated. The plates should have a V-bottom shape to facilitate the settling and observation of the RBCs. The plates should be clean and sterile, and labeled properly.

• Diluent: This is a buffer solution that is used to dilute the RBC suspension and the sample before mixing them in the wells. The diluent should have a pH and osmolarity that are compatible with the RBCs and prevent their hemolysis or spontaneous agglutination. A common diluent used for hemagglutination assay is phosphate-buffered saline (PBS).

• Negative and positive control samples: These are samples that are known to give negative and positive results, respectively, in the hemagglutination assay. They are used to validate the assay performance and compare it with the test samples. The control samples should be prepared and stored in the same way as the test samples and diluted to the same concentration.

• RDT kits: These are ready-to-use kits that contain all the necessary reagents and materials to perform a rapid hemagglutination assay (RHA). The RHA is a simplified version of the hemagglutination assay that can be done on a glass slide or a tile within one minute. The RDT kits usually include slides, reagents, controls, and instructions for use.

These are the basic requirements for performing a hemagglutination assay. Depending on the type and purpose of the assay, some additional requirements may be needed, such as pipettes, tips, loops, incubators, timers, microscopes, etc. The hemagglutination assay is a versatile and reliable method that can be used for various applications in immunology, microbiology, virology, and blood typing.

The main idea behind the hemagglutination assay is that when any antigens on the surface of red blood cells (RBCs) come into contact with any complementary antibody, they combine to agglutinate and form noticeable clumps, clearly distinguishing the positive test from the negative one.

The antigens and antibodies involved in the hemagglutination assay can be either natural or artificial. Natural antigens are those that are present on the RBCs due to genetic factors, such as ABO blood group antigens. Natural antibodies are those that are produced by the immune system against foreign RBCs, such as anti-A or anti-B antibodies. Artificial antigens are those that are attached to the RBCs by chemical or physical means, such as viral or bacterial antigens. Artificial antibodies are those that are produced by immunizing animals or humans with specific antigens, such as anti-viral or anti-bacterial antibodies.

The hemagglutination assay can be used to detect either antigens or antibodies in a given sample. For example, to detect antigens, RBCs coated with specific antibodies are mixed with the sample. If the sample contains the corresponding antigens, they will bind to the antibodies on the RBCs and cause them to clump together. This is called direct hemagglutination. To detect antibodies, RBCs coated with specific antigens are mixed with the sample. If the sample contains the corresponding antibodies, they will bind to the antigens on the RBCs and cause them to clump together. This is called indirect hemagglutination.

The degree of hemagglutination depends on several factors, such as the concentration and affinity of the antigens and antibodies, the size and shape of the RBCs, the pH and temperature of the reaction, and the presence of inhibitors or enhancers. The hemagglutination assay can be performed in different formats, such as slide agglutination, tube agglutination, microplate agglutination, or latex agglutination. The results can be read visually by observing the presence or absence of clumps or quantitatively by measuring the optical density or turbidity of the reaction.

The hemagglutination assay is a simple, inexpensive, and versatile method for detecting various infectious agents, blood groups, and immune responses. However, it also has some limitations, such as false-positive or false-negative results due to non-specific agglutination or inhibition, low sensitivity or specificity compared to other methods, and subjective interpretation of results depending on the observer. Therefore, it is important to perform the assay under optimal conditions and with appropriate controls and standards.

Hemagglutination assays can be classified into two main types based on the methodology: direct and indirect. In direct hemagglutination assays, the red blood cells (RBCs) are coated with antigens that can bind to specific antibodies in the test sample. In indirect hemagglutination assays, the RBCs are coated with antibodies that can bind to specific antigens in the test sample. The principle of both types is the same: the formation of visible clumps of RBCs indicates a positive reaction.

Direct and indirect hemagglutination assays can be further divided into subtypes based on the mode of detection, the type of RBCs used, and the purpose of the assay. Some of the common subtypes are:

• Micro-hemagglutination assay: This is a more sensitive and accurate method that can detect and quantify the amount of hemagglutinin in a test sample. It is performed on a microtiter plate with 96 wells that have V-shaped or U-shaped bottoms. The test sample is serially diluted and added to each well along with 1% RBCs. The plate is incubated for about 40 minutes and then observed by eye or with a plate reader. A positive result shows a distinct button of RBCs at the bottom of the well, while a negative result shows an even suspension of RBCs.

• Hemagglutination inhibition assay: This is a variation of the direct hemagglutination assay that can measure the number of antibodies in a test sample that can inhibit the hemagglutination reaction. It is used to diagnose viral infections such as influenza, measles, mumps, rubella, etc. The test sample is mixed with a known amount of viral antigen and then added to RBCs coated with the same antigen. If the test sample contains antibodies against the antigen, they will block the binding sites on the RBCs and prevent hemagglutination. The degree of inhibition is proportional to the antibody concentration in the test sample.

• Reverse passive hemagglutination assay: This is a variation of the indirect hemagglutination assay that can detect very low levels of antigens in a test sample. It is used to diagnose bacterial infections such as meningitis, pneumonia, septicemia, etc. The test sample is added to RBCs coated with antibodies against the target antigen. If the test sample contains the antigen, it will bind to the antibodies on the RBCs and cause hemagglutination. The sensitivity of this assay can be enhanced by using latex particles or magnetic beads instead of RBCs as carriers.

• Hemadsorption assay: This is another variation of the indirect hemagglutination assay that can detect viral antigens on infected cells. It is used to identify viral strains and monitor viral replication. The test sample consists of cells infected with a virus that expresses hemagglutinin on its surface. These cells are added to RBCs coated with antibodies against the viral hemagglutinin. If the cells are infected, they will adsorb the RBCs and form clumps that can be seen under a microscope.

These are some of the common types of hemagglutination assays that have various applications in clinical and research settings. They are based on the same principle but differ in their specificity, sensitivity, speed, and cost.

Assay for Rapid Hemagglutination

This test, as the name implies, can determine the presence of a haemagglutinating agent in about one minute. As a result, it is also known as the Rapid Diagnosis Test (RDT). When testing multiple samples, the negative and positive control samples must be tested only once.

The settling pattern of the red blood cell suspension must be tested whenever a haemagglutination test is performed. This is accomplished by combining diluent and allowing red blood cells to settle.

• The diluent should be dispensed.

• Add red blood cells and gently shake them to combine.

• Before examining the pattern, allow the red blood cells to settle.

• Examine the cells to ensure that they are forming in a normal pattern and that no auto-agglutination is occurring.

In the rapid assay, there will be a distinct button of cells and an even suspension with no signs of clumping in the micro-agglutination assay.

Rapid Hemagglutination Assay Procedure

• Apply four separate drops of 10% chicken red blood cells to a glass slide or the kit`s provided one.

• Add one drop of each control and test sample, along with PBS, to each drop of blood. Use separate tips, pipettes, or a flamed loop to dispense each sample.

• PBS is dropped first, followed by control and unidentified samples.

• Mix it for one minute by rotating the slide or tile.

• To analyze the result, observe it and compare it to the positive and negative controls provided in the kit.

The rapid hemagglutination assay is a simple and quick method to detect the presence of hemagglutinating agents in a sample. The procedure involves the following steps:

1. Prepare a 10% suspension of chicken red blood cells (RBCs) in phosphate-buffered saline (PBS). This can be done by mixing 1 ml of chicken blood with 9 ml of PBS and centrifuging at low speed to remove the plasma and buffy coat. Resuspend the RBCs in PBS to obtain a 10% suspension.

1. Place four separate drops of the RBC suspension on a glass slide or a plastic tile. Label the drops as A, B, C, and D.

1. Add one drop of PBS to drop A. This will serve as a negative control to check for any auto-agglutination of RBCs.

1. Add one drop of a positive control serum or antigen to drop B. This will serve as a positive control to show the expected hemagglutination reaction.

1. Add one drop of the test serum or antigen to drop C. This will show the presence or absence of hemagglutinating agents in the sample.

1. Add one drop of another test serum or antigen to drop D. This can be used to compare different samples or test for cross-reactivity.

1. Mix each drop gently by rotating the slide or tile for one minute. Avoid spilling or mixing the drops with each other.

1. Observe the results under a bright light or a magnifying glass. Look for the formation of clumps or aggregates of RBCs in each drop.

1. Compare the results with the positive and negative controls. A positive result is indicated by visible clumping of RBCs, while a negative result is indicated by an even distribution of RBCs on the slide or tile.

The rapid hemagglutination assay can be used to detect various viral and bacterial infections, such as influenza, mumps, measles, rubella, syphilis, and hepatitis B. It can also be used to determine blood types and Rh factors.

Here is an example of how the results may look like:

In this example, drop A shows no clumping, indicating no auto-agglutination of RBCs. Drop B shows clumping, indicating a positive control reaction. Drop C shows clumping, indicating a positive test result for the sample. Drop D shows no clumping, indicating a negative test result for another sample.

This method is useful for testing the presence or absence of haemagglutinin in allantoic fluid from many embryonated eggs. It is a more time-consuming method than RDT. Red blood cells are dissolved in a 1% solution. Cells settle faster in V-bottom plates, and the slight difference between positive and negative results is greater than in U-bottom plates.

The micro-hemagglutination assay is based on the principle that haemagglutinin present in the allantoic fluid will bind to the red blood cells and cause them to clump together. The clumps will form a distinct button at the bottom of the well, while the unbound red blood cells will remain in suspension. The presence or absence of haemagglutination can be observed by eye or with a microscope.

The micro-hemagglutination assay can be used to detect and quantify various viral infections, such as avian influenza, Newcastle disease, and infectious bronchitis. It can also be used to measure the potency of vaccines and anti-viral drugs. The micro-hemagglutination assay is more sensitive and specific than the rapid hemagglutination assay, but it requires more time and equipment.

The micro-hemagglutination assay has some advantages and limitations. Some of the advantages are:

• It can detect low levels of haemagglutinin in the allantoic fluid

• It can differentiate between different strains of viruses based on their haemagglutination patterns

• It can provide quantitative results by measuring the haemagglutination titers

Some of the limitations are:

• It requires fresh and standardized red blood cells from specific species

• It may be affected by non-specific agglutination caused by other factors in the allantoic fluid

• It may require confirmation by other methods, such as serological tests or virus isolation

This method is useful for testing the presence or absence of haemagglutinin in allantoic fluid from many embryonated eggs. It is a more time-consuming method than RDT. Red blood cells are dissolved in a 1% solution. Cells settle faster in V-bottom plates, and the slight difference between positive and negative results is greater than in U-bottom plates.

The following steps are involved in the micro-hemagglutination assay:

1. Fill out a recording sheet with information about the samples being tested. The samples and controls will be placed in the wells indicated on this sheet.

1. Take a sample of about 50 ml with a micropipette and dispense it into a well of the microwell plate. Use a different tip for each sample to prevent contamination of samples.

1. Place negative and positive controls on one of the plates.

1. Pour 50 mL of PBS into each well. These wells will serve as auto-agglutination controls for red blood cells.

1. Fill each well with 25 mL of 1% red blood cells.

1. Gently tap the plate`s sides to mix. Cover the plate with a plate cover.

1. Let the plate stand for about 40 minutes and observe/record the data.

The appearance of clumps in the case of agglutinated suspension can indicate a positive test in all tests. It can be compared with the positive control set to analyze properly. A positive test suggests that the respective sample is contaminated with antibodies or antigens related to a pathogen.

Note: The clumps can be observed at the bottom of the well in the case of Micro-well and on the surface in the case of RDT.

The result of a hemagglutination assay is based on the presence or absence of clumps of red blood cells in the wells or slides. The clumps indicate that the red blood cells have been agglutinated by the antigen or antibody present in the test sample. The absence of clumps indicates that there is no agglutination and hence no reaction between the test sample and the red blood cells.

The result can be compared with the positive and negative controls to confirm the validity of the test. A positive control is a sample that is known to contain the antigen or antibody of interest and should show agglutination. A negative control is a sample that is known to lack the antigen or antibody of interest and should not show agglutination.

The result can also be expressed as a titer, which is the reciprocal of the highest dilution of the test sample that still shows agglutination. For example, if a test sample shows agglutination at a 1:64 dilution but not at a 1:128 dilution, then the titer is 64. A higher titer indicates a higher concentration of the antigen or antibody in the test sample.

The result interpretation may vary depending on the type of hemagglutination assay and the purpose of the test. For example, in a hemagglutination inhibition test, which is used to detect antibodies against viral hemagglutinins, the absence of agglutination indicates a positive result, as it means that the antibodies have inhibited the virus from binding to the red blood cells. In contrast, in a direct hemagglutination test, which is used to detect antigens on the surface of red blood cells, such as blood groups, the presence of agglutination indicates a positive result, as it means that the antibodies have recognized and bound to the antigens.

Some factors that may affect the result interpretation include:

• The quality and specificity of the red blood cells and the test sample

• The optimal concentration and pH of the diluent

• The incubation time and temperature

• The presence of non-specific inhibitors or agglutinins

• The manual observation and recording of the results

Therefore, it is important to follow standard protocols and quality control measures when performing a hemagglutination assay.

Hemagglutination assay is a versatile technique that can be used for various purposes in clinical and research settings. Some of the applications of hemagglutination assay are:

• Blood typing and cross-matching: Hemagglutination assay can be used to determine the ABO and Rh blood groups of a person by using specific antibodies that agglutinate the red blood cells of different groups. It can also be used to test the compatibility of donor and recipient blood before transfusion by mixing them and observing for any agglutination reaction.

• Detection of antibodies and antigens: Hemagglutination assay can be used to detect the presence of antibodies or antigens in a serum sample by using red blood cells coated with the corresponding antigens or antibodies. For example, hemagglutination assay can be used to diagnose viral infections such as influenza, mumps, measles, rubella, etc., by using red blood cells coated with viral antigens and testing the serum sample for the presence of specific antibodies. Similarly, hemagglutination assay can be used to detect bacterial infections such as syphilis, leptospirosis, brucellosis, etc., by using red blood cells coated with bacterial antigens and testing the serum sample for the presence of specific antibodies.

• Quantification of viruses and antibodies: Hemagglutination assay can be used to measure the number of viruses or antibodies in a sample by performing serial dilutions and observing the highest dilution that still causes agglutination. The inverse of this dilution is called the hemagglutination titer and reflects the concentration of viruses or antibodies in the sample. For example, a hemagglutination assay can be used to quantify the viral load in a patient infected with HIV by using red blood cells coated with HIV antigens and testing the patients serum for the hemagglutination titer. Similarly, hemagglutination assay can be used to quantify the antibody level in a patient vaccinated against disease by using red blood cells coated with the vaccine antigen and testing the patients serum for the hemagglutination titer.

• Rapid diagnosis tests: Hemagglutination assay can be used to develop rapid diagnostic tests that can provide results within minutes without requiring sophisticated equipment or trained personnel. These tests are based on the principle of rapid hemagglutination assay and use slides or cards coated with red blood cells and reagents that can be easily mixed and observed. For example, rapid diagnostic tests based on hemagglutination assay are available for detecting hepatitis B surface antigen (HBsAg), human chorionic gonadotropin (hCG), rheumatoid factor (RF), etc.

Hemagglutination assay is a simple, inexpensive, and reliable technique that has many applications in medicine and biology. It can help in diagnosing diseases, monitoring infections, evaluating immune responses, and developing vaccines. However, it also has some limitations, such as sensitivity, specificity, standardization, and interpretation, that need to be considered while performing and analyzing the results.

Hemagglutination assay is a widely used technique for detecting and quantifying the presence of antibodies or antigens in a sample. It has several advantages over other methods, such as:

• Simple to perform: Hemagglutination assay does not require complex equipment or procedures. It can be performed on a glass slide or a microtiter plate with a few drops of reagents and samples. The result can be observed visually by the formation of clumps or buttons of red blood cells.

• Not as expensive as many other tests: Hemagglutination assay uses relatively cheap and easily available reagents, such as red blood cells, serum, and diluent. It does not require anti-species-specific secondary antibodies or highly purified antigens.

• Fast interpretation of results: Hemagglutination assay can provide results within minutes, especially in the case of rapid hemagglutination assay. The transition from agglutinated to non-agglutinated wells is usually distinct and clear.

• Sensitive and specific: Hemagglutination assay can detect low levels of antibodies or antigens in a sample, depending on the concentration and specificity of the red blood cells used. It can also differentiate between different serovars or strains of bacteria and viruses based on their antigenic differences.

Hemagglutination assay is a useful technique for detecting and quantifying various antigens and antibodies in biological samples. However, it also has some limitations that need to be considered before performing or interpreting the test. Some of the limitations are:

• False positives or negatives: Hemagglutination assay may produce false positive or negative results due to various factors, such as non-specific agglutination, auto-agglutination, prozone effect, cross-reactivity, interference by other substances, etc. For example, non-specific agglutination may occur when the RBCs or the reagents used are contaminated or expired. Auto-agglutination may occur when the RBCs are damaged or have intrinsic antigens that react with each other. The prozone effect may occur when the antibody concentration is too high and prevents the formation of visible clumps. Cross-reactivity may occur when the antigens or antibodies react with other similar molecules that are not the target of the test. Interference by other substances may occur when the sample contains lipids, proteins, drugs, or other compounds that affect the agglutination reaction.

• Sensitivity and specificity: Hemagglutination assay may not be sensitive or specific enough to detect low levels or rare types of antigens or antibodies in some cases. For example, some viral antigens may be present in very low amounts in the infected cells and may not be detected by hemagglutination assay. Some antibodies may have low affinity or avidity for their antigens and may not cause sufficient agglutination. Some antigens or antibodies may have multiple epitopes or paratopes and may require multiple types of RBCs or reagents to detect them.

• Standardization and quality control: Hemagglutination assay may not be standardized or quality-controlled enough to ensure consistent and reliable results across different laboratories or settings. For example, different sources or batches of RBCs or reagents may have different characteristics or properties that affect the agglutination reaction. Different methods or protocols for preparing, diluting, dispensing, mixing, incubating, and reading the samples may introduce variations or errors in the results. Different criteria or scales for interpreting the results may lead to discrepancies or confusion among different observers or users.

• Ethical and safety issues: Hemagglutination assay may raise some ethical and safety issues regarding the use of animal or human RBCs or sera as reagents or samples. For example, some animal RBCs may be obtained from animals that are killed or harmed for this purpose. Some human RBCs or sera may be obtained from donors who are not informed or consented for this purpose. Some RBCs or sera may carry infectious agents that pose a risk of transmission to the workers or the environment.

These limitations do not mean that the hemagglutination assay is invalid or useless. They only mean that hemagglutination assay should be performed and interpreted with caution and care, taking into account the possible sources of error and variation. Hemagglutination assay should also be complemented by other methods or tests that can confirm or refute its results. Hemagglutination assay is still a valuable technique that can provide useful information about various antigens and antibodies in a simple and inexpensive way.

We are Compiling this Section. Thanks for your understanding.